Sienna Biopharmaceuticals
(OTC) SNNAQ
Sienna Biopharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$47.91M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$0.00
Volume
2,216
Open
$0.00
Price
$0.00
Volume
2,216
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$0.00
Volume
2,216
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
SNNAQ News
SNNAQ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sienna Biopharmaceuticals
SNNAQ Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-92%
Return on Assets
-68%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
30.91M
Volume
2.22K
Short Interest
0.00%
Avg. Volume
36.933
Financials (TTM)
Gross Profit
$157.00K
Operating Income
$76.50M
EBITDA
$76.34M
Operating Cash Flow
$61.69M
Capital Expenditure
$39.00K
Free Cash Flow
$61.73M
Cash & ST Invst.
$48.53M
Total Debt
$30.13M
Sienna Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
13
N/A
Net Income
$3.97M
+76.4%
EBITDA
$8.80M
+48.9%
Quarterly Fundamentals
Net Cash
$11.33M
-66.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-68.32%
N/A
Return on Invested Capital
-92.21%
N/A
Free Cash Flow
$17.84M
-12.2%
Operating Cash Flow
$17.84M
-12.3%